Antagonists of angiotensin II containing N-methyl-L-alanine and DL-nipecotic acid in position 7.
[1-sarcosine, 7-N-methyl-L-alanine, 8-isoleucine]-Angiotensin II and [1-sarcosine, 7-DL-nipecotic acid, 8-isoleucine]-angiotensin II were synthesized by the solid-phase method and purified by cation-exchange chromatography and high-pressure liquid chromatography. In the isolated rat uterus these analogs and less than 0.1% of the myotropic activity of angiotensin II and inhibited angiotensin II with pA2 values of 8.2 and 7.8, respectively. In the rat pressor assay (vagotomized ganglion blocked rat) these analogs had 0.9 and 2.8%, respectively, of the pressor activity of angiotensin II. The results show that the proline residue in position 7 of [Sar1,Ile8]-angiotensin II may be replaced by other secondary amino acids without disrupting interactions at angiotensin II receptors.
D000595:Amino Acid Sequence; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D007098:Imino Acids / Q000378:metabolism*; D009119:Muscle Contraction; D009557:Nipecotic Acids / Q000378:metabolism; D011392:Proline / Q000378:metabolism; D051381:Rats; D014599:Uterus / Q000502:physiology
D007098:Imino Acids; D009557:Nipecotic Acids; D000804:Angiotensin II; D011392:Proline